Biochemistry, Genetics and Molecular Biology
Adiponectin
8%
Apolipoprotein B
85%
Apolipoprotein C
14%
Association
13%
Atorvastatin
29%
Blood Level
16%
Breathing
10%
Catabolism
43%
Cholesterol
57%
Cholesteryl Ester
8%
Chylomicron
17%
Clearance
13%
Comprehension
7%
Development
7%
Dose
10%
Dyslipidemia
19%
Electric Potential
7%
Emulsion
8%
Familial Hypercholesterolemia
15%
Fat
9%
Fenofibrate
7%
Fish Oil
13%
High-Density Lipoprotein
34%
Homeostasis
8%
Hypobetalipoproteinemia
12%
Insulin
9%
Insulin Resistance
14%
Intermediate-Density Lipoprotein
11%
Kexin
12%
Kinetics
100%
Leucine
10%
Lipid
8%
Lipoprotein
58%
Lipoprotein Blood Level
11%
Lipoprotein Metabolism
45%
Low-Density Lipoprotein
45%
Metabolic Pathway
62%
Mutation
8%
Postmenopause
9%
Proprotein Convertase
12%
Protein
13%
Reduction (Chemistry)
13%
Regulatory Mechanism
7%
Rosuvastatin
12%
Secretion (Process)
29%
Subtilisin
12%
Triacylglycerol Blood Level
8%
Triglyceride-Rich Lipoprotein
27%
Very Low-Density Lipoprotein
42%
Weight
7%
Medicine and Dentistry
Adiponectin
5%
Adipose Tissue
9%
Apolipoprotein
9%
Apolipoprotein A
6%
Apolipoprotein B
13%
Apolipoprotein B100
15%
Apolipoprotein B48
6%
Apolipoprotein C3
11%
Association
12%
Atorvastatin
5%
Catabolism
15%
Cholesterol
7%
Combination Therapy
6%
Dyslipidemia
9%
Familial Hypercholesterolemia
7%
Insulin Resistance
8%
Lipid
6%
Lipoprotein
24%
Lipoprotein Metabolism
12%
Low-Density Lipoprotein
9%
Man
24%
Maturity Onset Diabetes of the Young
9%
Metabolic Syndrome
10%
Metabolism
21%
Niacin
8%
Obesity
17%
Patient
10%
Plasma
38%
Predictor
9%
Proprotein Convertase 9
8%
Radioactive Tracer
5%
Secretion (Process)
11%
Stable Isotope
5%
Statin
12%
Therapeutic Procedure
8%
Triacylglycerol
11%
Triglyceride-Rich Lipoprotein
5%
Very Low Density Lipoprotein
23%
Pharmacology, Toxicology and Pharmaceutical Science
Apolipoprotein
6%
Apolipoprotein A
11%
Apolipoprotein B
15%
Apolipoprotein B100
30%
Apolipoprotein B48
12%
Atorvastatin
14%
Bempedoic Acid
5%
Cholesterol
21%
Chylomicron Remnant
6%
Dihydroartemisinin
5%
Dyslipidemia
6%
Familial Hypercholesterolemia
10%
Familial Hypobetalipoproteinemia
7%
High Density Lipoprotein
11%
High Density Lipoprotein Cholesterol
5%
Hyperlipidemia
6%
Insulin
5%
Intermediate Density Lipoprotein
8%
Lipoprotein
33%
Lipoprotein A
10%
Low Density Lipoprotein
20%
Low Density Lipoprotein Cholesterol
10%
Low Density Lipoprotein Receptor
7%
Metabolic Syndrome X
15%
Nicotinic Acid
7%
Non Insulin Dependent Diabetes Mellitus
10%
Pharmacodynamics
5%
Placebo
8%
Rosuvastatin
8%
Stable Isotope
5%
Statin (Protein)
20%
Tracer
9%
Triacylglycerol
20%
Very Low Density Lipoprotein
27%